Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Lamb

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Journal of Crohn'S & Colitis|January 23, 2026
Comparative analysis of inflammatory bowel disease patient and service reported quality of care using 2019 and 2023 UK benchmarking data from more than 26,000 adult patient respondents and 154 IBD servicesA Barney Hawthorne, Paul Christiansen, Ian Arnott, et al.
Journal of Crohn'S & Colitis|October 29, 2020
The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal InflammationAndrew Nelson, Christopher J Stewart, Nicholas A Kennedy, et al.
Gut|December 18, 2021
Distinct gene expression profiles between human preterm-derived and adult-derived intestinal organoids exposed to <i>Enterococcus faecalis</i>: a pilot studyAndrea C Masi, Tatiana Y Fofanova, Christopher A Lamb, et al.
Gastro Hep Advances|August 12, 2024
Phase II Feasibility Study of the Efficacy, Tolerability, and Impact on the Gut Microbiome of a Low-Residue (Fiber) Diet in Adult Patients With Mitochondrial DiseaseDavid Houghton, Yi Shiau Ng, Matthew A Jackson, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
Frontline Gastroenterology|August 15, 2023
Establishing key performance indicators for inflammatory bowel disease in the UKMohammed Nabil Quraishi, Elizabeth Dobson, Rachel Ainley, et al.
BMJ Open Gastroenterology|February 1, 2022
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort studyShaji Sebastian, Kamal V Patel, Jonathan P Segal, et al.
Frontiers in Nutrition|May 24, 2017
Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding TrialsNicholas D Embleton, Janet E Berrington, Jon Dorling, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2021
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort studyChristopher A Lamb, Shaji Sebastian, Alexandra J Kent, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2022
Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patientsA Barney Hawthorne, Jackie Glatter, Jonathan Blackwell, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Journal of Crohn'S & Colitis|January 23, 2026
Comparative analysis of inflammatory bowel disease patient and service reported quality of care using 2019 and 2023 UK benchmarking data from more than 26,000 adult patient respondents and 154 IBD servicesA Barney Hawthorne, Paul Christiansen, Ian Arnott, et al.
Journal of Crohn'S & Colitis|October 29, 2020
The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal InflammationAndrew Nelson, Christopher J Stewart, Nicholas A Kennedy, et al.
Gut|December 18, 2021
Distinct gene expression profiles between human preterm-derived and adult-derived intestinal organoids exposed to <i>Enterococcus faecalis</i>: a pilot studyAndrea C Masi, Tatiana Y Fofanova, Christopher A Lamb, et al.
Gastro Hep Advances|August 12, 2024
Phase II Feasibility Study of the Efficacy, Tolerability, and Impact on the Gut Microbiome of a Low-Residue (Fiber) Diet in Adult Patients With Mitochondrial DiseaseDavid Houghton, Yi Shiau Ng, Matthew A Jackson, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
Frontline Gastroenterology|August 15, 2023
Establishing key performance indicators for inflammatory bowel disease in the UKMohammed Nabil Quraishi, Elizabeth Dobson, Rachel Ainley, et al.
BMJ Open Gastroenterology|February 1, 2022
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort studyShaji Sebastian, Kamal V Patel, Jonathan P Segal, et al.
Frontiers in Nutrition|May 24, 2017
Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding TrialsNicholas D Embleton, Janet E Berrington, Jon Dorling, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2021
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort studyChristopher A Lamb, Shaji Sebastian, Alexandra J Kent, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2022
Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patientsA Barney Hawthorne, Jackie Glatter, Jonathan Blackwell, et al.
Pageof 11